Clinical trial
Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine Over 3 Years of Treatment. A
NCT03606356 is registered in ClinicalTrials.gov with Corfu Headache Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine Over 3 Years of Treatment. A
- Lead sponsor
- Corfu Headache Clinic
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 1, 2015
- Completion date
- April 1, 2018
- Enrollment
- 56 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.